Solving the mystery of named resources in life sciences project management

Solving the mystery of named resources in life sciences project management

Access webinar on-demand

Watch this webinar to know how named resource allocation solution (Alloc8) can help to streamline the project management process in an organization. Fill out the form to access the recording.

Speakers:

Dave Pendorff
Dave Pendorff
Strategic advisor-PPM
An expert in PPM processes and systems, with 17 years at Planisware and member of Groundwell Pharma Consortium.
Himanshu Arora
Himanshu Arora
Practice lead-PPM
Microsoft certified PPM expert with 14+ years' experience in consulting, deployment and implementation of digital portfolio management solutions to global life sciences organizations.

Moderator:

Vivek Kadam
Vivek Kadam
Sr. Manager - Business Development

Named resource management in life sciences project management is a complex challenge due to shifting priorities, long project durations, and the need for structured visibility. Named resource management defines roles, skills, processes in a formalized manner to offer visibility to product teams and management on individual resource utilization. Traditional tools like Excel and spreadsheets demand extensive manual effort and lack scalability, making it difficult for organizations to track resource utilization efficiently. To address these challenges, our webinar brought together industry experts to discuss how structured named resource management can enhance project success.

Agenda:

  1. What are named resources and why to structure them in life sciences project management?
  2. Ways named resources are managed across small and medium to large enterprises.
  3. Bringing granularity and visibility into named resources.
  4. Data integration- the critical aspect in managing named resources.
  5. Success stories of named resource management via a centralized solution.

Who should attend?

  • Portfolio leaders and strategic decision makers
  • R&D leaders and project managers overseeing drug development pipelines
  • Biotech companies with pipeline clinical assets